Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study

Table 2 In-hospital and readmission adverse events and interventions of the cohort (n = 519)

Adverse events	n	Interventions	n
Patients with any in-hospital adverse event	261	Patients with any in-hospital intervention	112
At HIPEC hospital only	221	At HIPEC hospital only	96
At both hospitals	17	At both hospitals	4
At referral hospital only	23	At referral hospital only	12
Patients with any HIPEC-related readmission adverse event	129	Patients with any readmission intervention	67
Total number of patients with any HIPEC-related adverse event within 6 months	319	Total number of patients with any HIPEC-related intervention within 6 months	158

ISSN: 1477-7819